AMPA- and kainate-receptors differentially mediate excitatory amino acid-induced dopamine and acetylcholine release from rat striatal slices

Neuropharmacology

Volumn 36, Issue 11-12, 1997, Pages 1503-1510

  S, Jin ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

CNQX; Concanavalin A; Cyclothiazide; NBQX; Non NMDA receptors; Transmitter release

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; ASCORBIC ACID; CONCANAVALIN A; CYCLOTHIAZIDE; EXCITATORY AMINO ACID; KAINIC ACID RECEPTOR; NOMIFENSINE; PARGYLINE; RECEPTOR SUBTYPE;

ACETYLCHOLINE RELEASE; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DESENSITIZATION; DOPAMINE RELEASE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; RAT;

EID: 0345487500     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(97)00166-4     Document Type: Article

References (42)

1. Bernard V., Gardiol A., Faucheux B., Bloch B., Agid Y. and Hirsch E. C. (1996) Expression of glutamate receptors in the human and rat basal ganglia: effect of the dopaminergic denervation on AMPA receptor gene expression in the striatopallidal complex in Parkinson's disease and rat with 6-OHDA lesion. Journal of Comparative Neurology 368: 553-568.
2. 3H]L-glutamate release from rat hippocampal synaptosomes. British Journal of Pharmacology 113: 339-341.
3. Bettler B. and Mulle C. (1995) Review: Neurotransmitter receptors II AMPA and kainate receptors. Neuropharmacology 34: 123-139.
4. Bouyer J. J., Park D. H., Joh T. H. and Pickel V. M. (1984) Chemical and structural analysis of the relation between cortical inputs and tyrosine hydroxylase-containing terminals in rat neostriatum. Brain Research 302: 267-275.
5. 14C]acetylcholine release from rat cortex. Journal of Pharmacology and Experimental Therapeutics 277: 193-197.
6. Carter C. J., L'Heureux R. and Scatton B. (1988) Differential control by N-methyl-D-aspartate and kainate of striatal dopamine release in vivo: a trans-striatal dialysis study. Journal of Neurochemistry 51: 462-468.
7. David J. C., Yamada K. A., Bagwe M. R. and Goldberg M. P. (1996) AMPA receptor activation is rapidly toxic to cortical astrocytes when desensitization is blocked. Journal of Neuroscience 16: 200-209.
8. 3H]norepinephrine release from rat hippocampal slices. Journal of Neurochemistry 63: 231-237.
9. Desai M. A., Burnett J. P., Ornstein P. L. and Schoepp D. D. (1995) Cyclothiazide acts at a site on the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor complex that does not recognize competitive or non competitive AMPA receptor antagonists. Journal of Pharmacology and Experimental Therapeutics 272: 38-43.
10. 3H]-acetylcholine release from rat hippocampus. Journal of Neurochemistry 54: 1386-1390.
11. Gerfen C. R. (1992) The neostriatal mosaic: multiple levels of compartmental organization. Trends in Neurosciences 15: 133-139.
12. Giovannini M. G., Camilli F., Mundula A., Bianchi L., Colivicchi M. A. and Pepeu G. (1995) Differential regulation by W-methyl-D-aspartate and non-N-methyl-D-aspartate receptors of acetylcholine release from the rat striatum in vivo. Neuroscience 65: 409-415.
13. Glavin G. B., Pinsky C. and Bose R. (1990) Domoic acid-induced neurovisceral toxic syndrome: characterization of an animal model and putative antidotes. Brain Research Bulletin 24: 701-703.
14. Jin S. and Fredholm B. B. (1994) Role of NMDA, AMPA and kainate receptors in mediating glutamate-and 4-AP-induced dopamine and acetylcholine release from rat striatal slices. Neuropharmacology 331: 1039-1048.
15. Jin S. and Fredholm B. B. (1997) Electrically evoked dopamine and acetylcholine release from rat striatal slices perfused without magnesium: Regulation by glutamate acting on NMDA receptors. British Journal of Pharmacology 121: 1269-1276.
16. 3H]kainate binding. European Journal of Pharmacology 246: 195-204.
17. Johansen T. H., Chaudhary A. and Verdoorn T. A. (1995) Interactions among GYKI-52466, Cyclothiazide, and antiracetam at recombinant AMPA and kainate receptors. Molecular Pharmacology 48: 946-955.
18. Korczak B., Nutt S. L., Fletcher E. J., Hoo K. H., Elliott C. E., Rampersad V., McWhinnie E. A. and Kamboj R. K. (1995) cDNA cloning and functional properties of human glutamate receptor EAA3 (GluR5) in homomeric and heteromeric configuration. Receptors and Channels 3: 41-49.
19. Lerma J., Morales M., Vicente M. A. and Herreras O. (1997) Glutamate receptors of the kainate type and synaptic transmission. Trends in Neurosciences 20: 9-12.
20. Martin L. J., Blackstone C. D., Levey A. I., Huganir R. L. and Price D. L. (1993) AMPA glutamate receptor subunits are differentially distributed in rat brain. Neuroscience 53: 327-358.
21. Milusheva E., Doda M., Pasztor E., Lajtha A., Sershen H. and Vizi E. S. (1992) Regulatory interactions among axon terminals affecting the release of different transmitters from rat striatal slices under hypoxic and hypoglycemic conditions. Journal of Neurochemistry 59: 946-952.
22. Mori H. and Mishina M. (1995) Structure and function of the NMDA receptor channel. Neuropharmacology 34: 1219-1237.
23. Nakanishi N., Shneider N. A. and Axel R. (1990) A family of glutamate receptor genes: evidence for the formation of heteromultimeric receptors with distinct channel properties. Neuron 5: 569-581.
24. Ohta K., Araki N., Shibata M., Komatsumoto S., Shimazu K. and Fukuuchi Y. (1994) Presynaptic ionotropic glutamate receptors modulate in vivo release and metabolism of striatal dopamine, noradrenaline, and 5-hydroxytryptamine: involvement of both NMDA and AMPA/kainate subtypes. Neuroscience Research 21: 83-89.
25. Olney J. W. (1990) Excitotoxicity: an overview. Canada Diseases Weekly Report 16 (Suppl 1E) 47-57.
26. Partin K. M., Patneau D. K., Winters C. A., Mayer M. L. and Buonanno A. (1993) Selective modulation of desensitization at AMPA versus kainate receptors by cyclothiazide and concanavalin A. Neuron 11: 1069-1082.
27. Patneau D. K., Wright P. W., Winters C., Mayer M. L. and Gallo V. (1994) Glial cells of the oligodendrocyte lineage express both kainate and AMPA preferring subtypes of glutamate receptors. Neuron 12: 357-371.
28. 3H]dopamine release from rat mesencephalic cells in primary culture. Journal of Neurochemistry 64: 1410-1412.
29. Pook P., Brugger F., Hawkins N. S., Clark K. C., Watkins J. C. and Evans R. H. (1993) A comparison of the actions of agonists and antagonists at non-NMDA receptors of C fibres and motoneurones of the immature rat spinal cord in vitro. British Journal of Pharmacology 108: 179-184.
30. Rang, H. P., Dale, M. M. and Ritter, J. M. (1995) Pharmacology, 3rd Edition, Section 4: The Central Nervous System. Churchill Livingstone, Edinburgh.
31. Richardson I. W. and Szerb J. C. (1974) The release of labelled acetylcholine and choline from electrically stimulated brain slices. British Journal of Pharmacology 52: 499-692.
32. 3H]dopamine release from rat striatum: an in vitro model for glutamate actions. Journal of Neurochemistry 32: 1539-1545.
33. Sheardown M. J., Nielsen E., Hansen A. J., Jacobsen P. and Honoré T. (1990) 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline: a neuroprotectant for cerebral ischemia. Science 247: 571-574.
34. Shell L. D. and Johnson K. M. (1986) Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs. Journal of Pharmacology and Experimental Therapeutics 238: 938-946.
35. Stein E., Cox J. A., Seeburg P. H. and Verdoorn T. A. (1992) Complex pharmacological properties of recombinant α-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor subtypes. Molecular Pharmacology 42: 864-871.
36. Stewart G. R., Zorumski C. F., Price M. T. and Olney J. W. (1990) Domoic acid: a dementia-inducing excitotoxic food poison with kainic acid receptor specificity. Experimental Neurology 110: 127-138.
37. Sutherland R. J., Hoesing J. M. and Whishaw I. Q. (1990) Domoic acid, an environmental toxin, produces hippocampal damage and severe memory impairment. Neuroscience Letters 120: 221-223.
38. Teitelbaum J. S., Zatorre R. J., Carpenter S. and Gendron D. (1990) Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels. New England Journal of Medicine 322: 1781-1787.
39. Verdoorn T. A., Kleckner N. W. and Dingledine R. (1989) N-Methyl-D-aspartate/glycine and quisqualate/kainate receptors expressed in Xenopus oocytes: antagonist pharmacology. Molecular Pharrmacology 35: 360-368.
40. Watkins J. C., Krogsgaard-Larsen P. and Honore T. (1990) Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists. Trends in Pharmacological Sciences 11: 25-33.
41. Wheeler D., Boutelle M. G. and Fillenz M. (1995) The role of N-methyl-D-aspartate receptors in the regulation of physiologically released dopamine. Neuroscience 65: 767-774.
42. Wong L. A. and Mayer M. L. (1993) Differential modulation by cyclothiazide and concanavalin A of desensitization at native α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and kainate preferring glutamate receptors. Journal of Pharmacology and Experimental Therapeutics 44: 504-510.